OOIR: Observatory of International Research

Papers

(The median citation count of Seminars in Fetal & Neonatal Medicine is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)

Article	Citations
The fetal inflammatory response syndrome: the origins of a concept, pathophysiology, diagnosis, and obstetrical implications	107
Have outcomes following extremely preterm birth improved over time?	59
Using rising tides to lift all boats: Equity-focused quality improvement as a tool to reduce neonatal health disparities	42
Prevention of preeclampsia	41
Neonatal encephalopathy: Focus on epidemiology and underexplored aspects of etiology	39
International comparisons of neurodevelopmental outcomes in infants born very preterm	36
Mechanisms of brain injury in newborn infants associated with the fetal inflammatory response syndrome	28
Long-term motor outcomes of very preterm and/or very low birth weight individuals without cerebral palsy: A review of the current evidence	27
Mental health outcomes of adults born very preterm or with very low birth weight: A systematic review	26
Genetic and epigenetic factors and early life inflammation as predictors of neurodevelopmental outcomes	26
Early developmental interventions for infants born very preterm – what works?	25
Oxidative stress biomarkers in the perinatal period: Diagnostic and prognostic value	25
Intermittent hypoxia and long-term neurological outcome: How are they related?	24
Pharmacokinetics, pharmacodynamics and metabolism of caffeine in newborns	22
Therapies for neonatal encephalopathy: Targeting the latent, secondary and tertiary phases of evolving brain injury	22
Neuroimaging in the term newborn with neonatal encephalopathy	21
Neonatal encephalopathy: Etiologies other than hypoxic-ischemic encephalopathy	20
Unanswered questions regarding therapeutic hypothermia for neonates with neonatal encephalopathy	19
Neurodevelopmental origins of social competence in very preterm children	18
Update on mechanisms of the pathophysiology of neonatal encephalopathy	18
Caffeine for preterm infants: Fixed standard dose, adjustments for age or high dose?	18
Oxygen saturation target ranges and alarm settings in the NICU: What have we learnt from the neonatal oxygenation prospective meta-analysis (NeOProM)?	17
“Health, wealth and achievements of former very premature infants in adult life”	17
Diagnosis and management of pulmonary hypertension in infants with bronchopulmonary dysplasia	17
LISA/MIST: Complex clinical problems almost never have easy solutions	16

Need for more evidence in the prevention and management of perinatal asphyxia and neonatal encephalopathy in low and middle-income countries: A call for action	16
Management of Neonatal Hypotension and Shock	16
Hemodynamic optimization for neonates with neonatal encephalopathy caused by a hypoxic ischemic event: Physiological and therapeutic considerations	15
Prevention of postpartum hemorrhage	15
Oxygen in the neonatal period: Oxidative stress, oxygen load and epigenetic changes	14
Oxygen metabolism and oxygenation of the newborn	14
Neurologic outcome after fetal inflammatory response syndrome: Trimester-specific considerations	14
Placental contribution to neonatal encephalopathy	13
Neurological and developmental outcomes following neonatal encephalopathy treated with therapeutic hypothermia	13
The neurobiological correlates of cognitive outcomes in adolescence and adulthood following very preterm birth	13
Neonatal white matter damage and the fetal inflammatory response	13
Supporting families in their child's journey with neonatal encephalopathy and therapeutic hypothermia	13
Superior vena cava flow: Role, assessment and controversies in the management of perinatal perfusion	13
Inter-center variability in neonatal outcomes of preterm infants: A longitudinal evaluation of 298 neonatal units in 11 countries	12
Management of comfort and sedation in neonates with neonatal encephalopathy treated with therapeutic hypothermia	12
A systematic review of reports of quality improvement for bronchopulmonary dysplasia	12
NIRS in the fetal to neonatal transition and immediate postnatal period	12
The use of data in resource limited settings to improve quality of care	11
Application and potential of artificial intelligence in neonatal medicine	11
Pulmonary hypertension and oxidative stress: Where is the link?	11
Oxygen therapy in preterm infants with pulmonary hypertension	11
Bedside and laboratory neuromonitoring in neonatal encephalopathy	11
Respiratory support of infants born at 22–24 weeks of gestational age	11
Small molecule biomarkers for neonatal hypoxic ischemic encephalopathy	11
Arterial spin labeling perfusion in neonates	11
Proposing a care practice bundle for neonatal encephalopathy during therapeutic hypothermia	10
Patent ductus arteriosus and cerebral, cardiac, and gut hemodynamics in premature neonates	10
Patent ductus arteriosus management and the drift towards therapeutic nihilism – What is the evidence?	10
Management of seizures in neonates with neonatal encephalopathy treated with hypothermia	10
National and international guidelines for neonatal caffeine use: Are they evidenced-based?	9
Evidence and practical aspects of treatment with the Tübingen palatal plate	9
Nutrition and management of glycemia in neonates with neonatal encephalopathy treated with hypothermia	9
Late adolescent & young adult functioning and participation outcomes after prematurity	9
When to say no to inhaled nitric oxide in neonates?	9
Assessment of neonatal perfusion	9
Early developmental screening and intervention for high-risk neonates - From research to clinical benefits	8
Outcomes from the other side	8
Closing the evidence to practice gap in neonatal transfusion medicine	8
Fluid management, electrolytes imbalance and renal management in neonates with neonatal encephalopathy treated with hypothermia	8
Cesarean delivery in low- and middle-income countries: A review of quality of care metrics and targets for improvement	8
Diagnosis & management of pulmonary hypertension in congenital diaphragmatic hernia	8
Transmission of SARS-CoV-2 from mother to fetus or neonate: What to know and what to do?	7
Impact of perinatal COVID on fetal and neonatal brain and neurodevelopmental outcomes	7
Harnessing mobile technology to deliver evidence-based maternal-infant care	7
Escaping the Finnegan – Is it time?	7
Challenges in respiratory management during therapeutic hypothermia for neonatal encephalopathy	7
Neurodevelopmental outcomes after neonatal caffeine therapy	7
Pregnancy and Severe ARDS with COVID-19: Epidemiology, Diagnosis, Outcomes and Treatment	7
Infection prevention for extremely low birth weight infants in the NICU	7
Personalized support of parents of extremely preterm infants before, during and after birth	7

Is caffeine available and affordable in low and middle-income countries? A survey in sub-Saharan Africa	7
Recovery of the brain after intraventricular hemorrhage	6
Quality improvement for NICU graduates: Feasible, relevant, impactful	6
Cannulation and decannulation techniques for neonatal ECMO	6
Home oxygen therapy after hospital discharge	6
The hypertensive neonate	6
Optimizing oxygen therapy for preterm infants at birth: Are we there yet?	6
Delayed cord clamping in healthy term infants: More harm or good?	6
Oxygen and pulmonary vasodilation: The role of oxidative and nitrosative stress	6
BPD treatments: The never-ending smorgasbord	6
Tissue engineering: Relevance to neonatal congenital heart disease	6
Milestones for clinical translation of the artificial placenta	6
Therapeutic interventions for fetal inflammatory response syndrome (FIRS)	6
Subcutaneous fat necrosis associated with hypercalcemia in neonates with neonatal encephalopathy treated with therapeutic hypothermia	6
Perinatal asphyxia from the obstetric standpoint	6
Advantages and disadvantages of mandibular distraction in Robin sequence	6
When to start and stop caffeine and why respiratory status matters	6
Optimizing initial neonatal resuscitation to reduce neonatal encephalopathy around the world	6
FIRS: Neonatal considerations	6
Neonatal ECMO survivors: The late emergence of hidden morbidities – An unmet need for long-term follow-up	5
The role of bedside functional echocardiography in the assessment and management of pulmonary hypertension	5
Neuroimaging findings associated with the fetal inflammatory response syndrome	5
Multisystem inflammatory disease in neonates (MIS-N) due to maternal COVID-19	5
Pulmonary hypertension in the newborn- etiology and pathogenesis	5
Feeding considerations for infants with craniofacial malformations	5
Genetics of craniofacial malformations	5
Caffeine exposure during pregnancy: Is it safe?	5
Multisystem inflammatory syndrome in neonates (MIS-N) associated with perinatal SARS CoV-2 infection: Does it exist?	5
Hemodynamic support of the micropreemie: Should hydrocortisone never be left out?	5
Cerebral palsy after very preterm birth - an imaging perspective	5
Intermittent hypoxia and bronchial hyperreactivity	5
Translational insights into mechanisms and preventive strategies after renal injury in neonates	5
Can we back off using antibiotics in the NICU?	5
Placental tissue stem cells and their role in neonatal diseases	4
Counseling for the option of termination of pregnancy for severe fetal anomalies in light of the recent Supreme Court ruling to remove the constitutional right to an abortion	4
Cooling in mild encephalopathy: Costs and perils of therapeutic creep	4
Medico-legal implications of the fetal inflammatory response syndrome	4
Maternal and neonatal outcomes following SARS-CoV-2 infection	4
Using continuous nasal airway pressure in infants with craniofacial malformations	4
General approach to delivery and resuscitation of newborn infants from mothers at risk or proven COVID-19	4
Chapter for antenatal steroids – Treatment drift for a potent therapy with unknown long-term safety seminars in fetal and neonatal medicine	4
Optimizing hemodynamic care in neonatal encephalopathy	4
Histopathology of the fetal inflammatory response to intra-amniotic pathogens	4
Pivotal challenges in artificial intelligence and machine learning applications for neonatal care	4
The implications of routine milk fortification for the short and long-term health of preterm babies	4
Nursing care of infants born extremely preterm	4
Management of hypertension in pregnancy	4
Newborn resuscitation devices: The known unknowns and the unknown unknowns	3
Expanding neonatal ECMO criteria: When is the premature neonate too premature	3
Perinatal care for the extremely preterm infant	3
Management of cardiac dysfunction in neonates with pulmonary hypertension and the role of the ductus arteriosus	3
Evaluation for the etiology of neonatal encephalopathy and the diagnosis of FIRS	3
Pulmonary vasodilator strategies in neonates with acute hypoxemic respiratory failure and pulmonary hypertension	3
Prenatal management of congenital diaphragmatic hernia	3
The epidemiology of FIRS in term and late preterm births	3
Oxygen for respiratory support of moderate and late preterm and term infants at birth: Is air best?	3
Technology in the delivery room supporting the neonatal healthcare provider's task	3
The neonatal liver: Normal development and response to injury and disease	3
Coagulation and hemolysis complications in neonatal ECLS: Role of devices	3
The unfinished work of neonatal very low birthweight infants quality improvement: Improving outcomes at a continental level in South America	3
Facilitating quality improvement through routinely recorded clinical information	3
Vaccination and treatment options for SARS-CoV2 infection affecting lactation and breastfeeding	3
Managing infants with craniofacial malformations – Where to go next?	3
Low blood sugar levels in the newborn infant: Do changing goal posts matter?	3
Medico-legal considerations in the context of neonatal encephalopathy and therapeutic hypothermia	3
Stem cells in neonatal diseases: An overview	3
What is bronchopulmonary dysplasia and does caffeine prevent it?	3
Oxygen saturation (SpO2) targeting for newborn infants at delivery: Are we reaching for an impossible unknown?	3